Open Access Open Access  Restricted Access Subscription Access

A Crucial Parameters of Human Papilloma Virus Include Patho Physiology, Histopathology, Diagnosis, Differential Diagnosis, Treatment, Prognosis and Complications

Srinivas G., Ramanjaneyulu D. V., Muralinath E., Guruprasad M., Sravani Pragna K., Manjari P., Sony Sharlet E., T. Nikhil, V. Yaswanth Sai, D. Kusuma Latha, Ch. Ramya Sudha, K. Sridevi, D. Gokul Shiva Balaji

Abstract


A non-enveloped, double-stranded, circular DNA virus, the human papillomavirus (HPV) is crucial for the development of numerous epithelial lesions and malignancies. Anogenital and cutaneous warts are possible symptoms, and depending on the subtype, they may develop into cancer. This exercise describes the assessment and treatment of human papillomavirus infection as well as the function of the interprofessional team in advancing patient care.


Full Text:

PDF

References


Bradbury, M., Xercavins, N., García-Jiménez, Á., Pérez-Benavente, A., Franco-Camps, S., Cabrera, S., Sánchez-Iglesias, J. L., De La Torre, J., Díaz-Feijoo, B., Gil-Moreno, A., & Centeno-Mediavilla, C. (2019). Vaginal intraepithelial neoplasia: Clinical presentation, management, and outcomes in relation to HIV infection status. Journal of Lower Genital Tract Disease, 23(1), 7–12. https://doi.org/10.1097/LGT.0000000000000462

Hirth, J. (2019). Disparities in HPV vaccination rates and HPV prevalence in the United States: A review of the literature. Human Vaccines & Immunotherapeutics, 15(1), 146–155. https://doi.org/10.1080/21645515.2018.1512453

Kobayashi, K., Hisamatsu, K., Suzui, N., Hara, A., Tomita, H., & Miyazaki, T. (2018). A review of HPV-related head and neck cancer. Journal of Clinical Medicine, 7(9), 241. https://doi.org/10.3390/jcm7090241

Araldi, R. P., Sant’Ana, T. A., Módolo, D. G., de Melo, T. C., Spadacci-Morena, D. D., de Cássia Stocco, R., Cerutti, J. M., & de Souza, E. B. (2018). The human papillomavirus (HPV)-related cancer biology: An overview. Biomedicine & Pharmacotherapy, 106, 1537–1556. https://doi.org/10.1016/j.biopha.2018.07.151

Van Dyne, E. A., Henley, S. J., Saraiya, M., Thomas, C. C., Markowitz, L. E., & Benard, V. B. (2018). Trends in human papillomavirus-associated cancers—United States, 1999–2015. Morbidity and Mortality Weekly Report, 67(33), 918–924. https://doi.org/10.15585/mmwr.mm6733a2

Nunes, E. M., Talpe-Nunes, V., & Sichero, L. (2018). Epidemiology and biology of cutaneous human papillomavirus. Clinics, 73(Suppl 1), e489s. https://doi.org/10.6061/clinics/2018/e489s

Heo, I., Kwak, H. J., Nah, E. H., Cho, S., Kim, S., & Cho, H. I. (2018). Evaluation of the LC-1000 flow cytometry screening system for cervical cancer screening in routine health checkups. Acta Cytologica, 62(4), 279–287. https://doi.org/10.1159/000489279

Kim, J. J., Burger, E. A., Regan, C., & Sy, S. (2018). Screening for cervical cancer in primary care: A decision analysis for the US Preventive Services Task Force. JAMA, 320(7), 706–714. https://doi.org/10.1001/jama.2018.4796

Deutsch, S. A., Benyo, S., Xie, S., Carlin, E., Andalaro, B., Clagg, B., & De Jong, A. (2018). Addressing human papillomavirus prevention during pediatric acute sexual assault care. Journal of Forensic Nursing, 14(3), 154–161. https://doi.org/10.1097/JFN.0000000000000212

Soe, N. N., Ong, J. J., Ma, X., Fairley, C. K., Latt, P. M., Jing, J., Cheng, F., & Zhang, L. (2018). Should human papillomavirus vaccination target women over age 26, heterosexual men and men who have sex with men? A targeted literature review of cost-effectiveness. Human Vaccines & Immunotherapeutics, 14(12), 3010–3018. https://doi.org/10.1080/21645515.2018.1500267

Buzard, C. L., & Rizzolo, D. (2018). An overview of anal intraepithelial neoplasia. JAAPA, 31(7), 1–5. https://doi.org/10.1097/01.JAA.0000530462.83583.d3

Cooper, C. P., & Saraiya, M. (2018). Cervical cancer screening intervals preferred by U.S. women. American Journal of Preventive Medicine, 55(3), 389–394. https://doi.org/10.1016/j.amepre.2018.04.017

Rositch, A. F., & Krakow, M. (2018). Invited commentary: Moving from evidence to impact for human papillomavirus vaccination—The critical role of translation and communication in epidemiology. American Journal of Epidemiology, 187(6), 1277–1280. https://doi.org/10.1093/aje/kwy037

Arrossi, S., Temin, S., Garland, S., Eckert, L. O., Bhatla, N., Castellsagué, X., Alkaff, S. E., Felder, T., Hammouda, D., Konno, R., Lopes, G., Mugisha, E., Murillo, R., Scarinci, I. C., Stanley, M., Tsu, V., Wheeler, C. M., Adewole, I. F., & de Sanjosé, S. (2017). Primary prevention of cervical cancer: American Society of Clinical Oncology resource-stratified guideline. Journal of Global Oncology, 3(5), 611–634. https://doi.org/10.1200/JGO.2016.008904

Ouh, Y. T., & Lee, J. K. (2018). Proposal for cervical cancer screening in the era of HPV vaccination. Obstetrics & Gynecology Science, 61(3), 298–308. https://doi.org/10.5468/ogs.2018.61.3.298


Refbacks

  • There are currently no refbacks.